Search DrRajHealth

Friday, December 8, 2017

Sunday, December 3, 2017

Members of Aggie band visit grandmother in hospital to sing Happy Birthday

Sweet woman and good family. Glad I got to know them. Best wishes.
from Rajesh Harrykissoon, MD

Saturday, December 2, 2017

ACA enrollment aid available for Brazos Valley residents at Santa Teresa Church

Bilingual navigators and health care enrollment specialists will be on-hand today at Santa Teresa Catholic Church from 9 a.m. to 2 p.m. to help Brazos Valley residents enroll in health insurance through the online marketplace.
from Rajesh Harrykissoon, MD

A man collapsed with ‘Do Not Resuscitate’ tattooed on his chest. Doctors didn’t know what to do.

“It also seemed that he didn't trust that his end-of-life wishes would be conveyed appropriately. So, to me, it means we need a better system. We need a better system for people to be able to convey their wishes — if these are their wishes — so that we don't do things to them that they don't want.” -Gregory Holt, a critical-care physician.
from Rajesh Harrykissoon, MD

Friday, November 17, 2017

eClinicalWorks sued for nearly $1 billion for inaccurate medical records

The claim of “breach of fiduciary duty“ is very interesting. Modern bioethics acknowledges that there exists cofiduciary obligations to the patient. No longer is the physician the sole fiduciary in the care of the patient. For instance, insurance companies condition access to care. The best orthopedic surgeon with excellent outcomes and lowest complications may be in your city, however, because that individual may not be “in network” with your insurance, your access to best care comes with a condition. There may be better devices or medications with proven superiority, reliability and performance, but because the facility may have pre-existing contracts you may not have access to those products. These are all examples of the import of cofiduciary obligations. Potential compromise in cofiduciary obligations to the patient is not uncommon. What is lacking is transparency to the patient regarding those potential compromises.
from Rajesh Harrykissoon, MD

Monday, November 6, 2017

The FDA just changed how it reviews genetic health risk tests

A favorable “patient-centered” change in policy. The information from these tests are interesting and relevant. I do agree that customers who order these tests appear more engaged in the results and potential health decisions—perhaps it’s a differentiator versus the more passive option of when your doctor orders testing. Had such testing been available 10 years ago when I was started on a statin medication, perhaps I would not have personally suffered a side effect of rhabdomyolysis (a predilection which was disclosed in the genetic testing).
from Rajesh Harrykissoon, MD